A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Huntington's disease: diagnosis and management. | LitMetric

Huntington's disease: diagnosis and management.

Pract Neurol

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Published: February 2022

AI Article Synopsis

  • Huntington's disease (HD) is a hereditary neurodegenerative disorder marked by neuropsychiatric symptoms, a movement disorder (mainly chorea), and cognitive decline, diagnosed by detecting increased CAG repeat lengths in the huntingtin gene.
  • While diagnosing HD is typically clear-cut, some patients present in atypical ways, complicating the identification of when an asymptomatic carrier develops the disease.
  • Managing HD effectively requires specialized multidisciplinary clinics, especially for genetic testing, as current treatments focus on alleviating symptoms like chorea and behavioral issues, though evidence supporting these treatments is often limited.

Article Abstract

Huntington's disease (HD) is an inherited neurodegenerative disease characterised by neuropsychiatric symptoms, a movement disorder (most commonly choreiform) and progressive cognitive impairment. The diagnosis is usually confirmed through identification of an increased CAG repeat length in the huntingtin gene in a patient with clinical features of the condition. Though diagnosis is usually straightforward, unusual presentations can occur, and it can be difficult to know when someone has transitioned from being an asymptomatic carrier into the disease state. This has become increasingly important recently, with several putative disease-modifying therapies entering trials. A growing number of conditions can mimic HD, including rare genetic causes, which must be considered in the event of a negative HD genetic test. Patients are best managed in specialist multidisciplinary clinics, including when considering genetic testing. Current treatments are symptomatic, and largely directed at the chorea and neurobehavioural problems, although supporting trial evidence for these is often limited.

Download full-text PDF

Source
http://dx.doi.org/10.1136/practneurol-2021-003074DOI Listing

Publication Analysis

Top Keywords

huntington's disease
8
disease diagnosis
4
diagnosis management
4
management huntington's
4
disease inherited
4
inherited neurodegenerative
4
neurodegenerative disease
4
disease characterised
4
characterised neuropsychiatric
4
neuropsychiatric symptoms
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!